Tel: 0755-85269922 E-mail: sales@biochemmall.com
ICP:粤ICP备19135875号
Cabozantinib (XL184, BMS-907351) is a potent inhibitor of VEGFR2 with an IC50 of 0.035 nM in cell-free trials and is capable of inhibiting c-Met, Ret, Kit, Flt-1/3/4, Tie2 and AXL, IC50 were 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively. Cabozantinib induces Puma-dependent apoptosis in colon cancer cells via the AKT/GSK-3β/NF-κB signaling pathway.
Brand: BCM
Melting Point: 212-215°C
pKa: 13.86±0.70(Predicted)
Solubility: Soluble in DMSO. Insoluble in Water and Ethanol.
Attribute [CAS No.] 849217-68-1 [Formula] C28H24FN3O5 [Molecular] 502 [Chem Name] 1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)- [Synonym] Cabozantinib; XL184; BMS-907351 [Storage] -20°C [EINECS] 692-846-8 [MDL No.] MFCD20926324 [Form] White powder
Goods Tag